Literature DB >> 15308568

Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase.

Elizabeth E Gardiner1, Jane F Arthur, Mark L Kahn, Michael C Berndt, Robert K Andrews.   

Abstract

Thrombosis can be initiated when activated platelets adhere to injured blood vessels via the interaction of subendothelial collagen with its platelet receptor, glycoprotein (GP) VI. Here we observed that incubation of platelets with convulxin, collagen, or collagen-related peptide (CRP) resulted in GPVI signaling-dependent loss of surface GPVI and the appearance of an approximately 55-kDa soluble fragment of GPVI as revealed by immunoblotting. Ethylenediaminetetraacetic acid (EDTA) or GM6001 (a metalloproteinase inhibitor with broad specificity) prevented this loss. In other receptor systems, calmodulin binding to membrane-proximal cytoplasmic sequences regulates metalloproteinase-mediated ectodomain shedding. In this regard, we have previously shown that calmodulin binds to a positively charged, membrane-proximal sequence within the cytoplasmic tail of GPVI. Incubation of platelets with calmodulin inhibitor W7 (150 microM) resulted in a time-dependent loss of GPVI from the platelet surface. Both EDTA and GM6001 prevented this loss. Surface plasmon resonance demonstrated that W7 specifically blocked the association of calmodulin with an immobilized synthetic peptide corresponding to the calmodulin-binding sequence of GPVI. These findings suggest that disruption of calmodulin binding to receptor cytoplasmic tails by agonist binding to the receptor triggers metalloproteinase-mediated loss of GPVI from the platelet surface. This process may represent a potential mechanism to regulate GPVI-dependent platelet adhesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308568     DOI: 10.1182/blood-2004-04-1549

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Transmembrane and trans-subunit regulation of ectodomain shedding of platelet glycoprotein Ibalpha.

Authors:  Xi Mo; Nam X Nguyen; Fi-Tjen Mu; Wenjun Yang; Shi-Zhong Luo; Huizhou Fan; Robert K Andrews; Michael C Berndt; Renhao Li
Journal:  J Biol Chem       Date:  2010-08-17       Impact factor: 5.157

2.  Deciphering the human platelet sheddome.

Authors:  Karen P Fong; Colin Barry; Anh N Tran; Elizabeth A Traxler; Kenneth M Wannemacher; Hsin-Yao Tang; Kaye D Speicher; Ian A Blair; David W Speicher; Tilo Grosser; Lawrence F Brass
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

3.  Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients.

Authors:  Paul Vulliamy; Samantha J Montague; Scarlett Gillespie; Melissa V Chan; Lucy A Coupland; Robert K Andrews; Timothy D Warner; Elizabeth E Gardiner; Karim Brohi; Paul C Armstrong
Journal:  Blood Adv       Date:  2020-06-23

4.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

5.  Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Nandan K Mondal; Zengsheng Chen; Jaimin R Trivedi; Erik N Sorensen; Si M Pham; Mark S Slaughter; Bartley P Griffith; Zhongjun J Wu
Journal:  ASAIO J       Date:  2018 Jul/Aug       Impact factor: 2.872

6.  Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage.

Authors:  Ehteramolsadat Hosseini; Pezhman Beshkar; Mehran Ghasemzadeh
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

7.  Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects.

Authors:  Constance C F M J Baaten; Frauke Swieringa; Tomasz Misztal; Tom G Mastenbroek; Marion A H Feijge; Paul E Bock; Marjo M P C Donners; Peter W Collins; Renhao Li; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Blood Adv       Date:  2018-09-25

8.  Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets.

Authors:  Weidong Jing; Mehmet Yabas; Angelika Bröer; Lucy Coupland; Elizabeth E Gardiner; Anselm Enders; Stefan Bröer
Journal:  Blood Adv       Date:  2019-02-12

9.  Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site.

Authors:  X Liang; S R Russell; S Estelle; L H Jones; S Cho; M L Kahn; M C Berndt; S T Bunting; J Ware; R Li
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

10.  A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex.

Authors:  Hiroshi Takayama; Yoshitaka Hosaka; Kazuyuki Nakayama; Kamon Shirakawa; Katsuki Naitoh; Tomokazu Matsusue; Mikihiko Shinozaki; Motoyasu Honda; Yukiko Yatagai; Tetsushi Kawahara; Jiro Hirose; Tooru Yokoyama; Michiru Kurihara; Shoji Furusako
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.